You may be right.On the other hand, you may very well be...

You may be right.

On the other hand, you may very well be wrong.

If present experimental work gives poor results, I would expect the company to be wound up in the near term with a cash distribution that would not likely exceed 4.5 cents per share.

On the other hand, if the oral insulin is shown to be effective in pigs or a primate, then don't expect an early demise. The next few months should be determinative.